BG
IMUC

BlackRock Group’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

BlackRock Group’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-894
Closed -$92K – 2955
2013
Q3 		$92K Buy
+894
New +$92K ﹤0.01% 2603